Azzad Asset Management Inc. ADV Invests $436,000 in Simulations Plus, Inc. (NASDAQ:SLP)

Azzad Asset Management Inc. ADV bought a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 17,785 shares of the technology company's stock, valued at approximately $436,000. Azzad Asset Management Inc. ADV owned approximately 0.09% of Simulations Plus at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Jones Financial Companies Lllp raised its holdings in shares of Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock valued at $34,000 after purchasing an additional 427 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Simulations Plus in the 4th quarter valued at about $39,000. Fifth Third Bancorp increased its stake in Simulations Plus by 33.8% in the 1st quarter. Fifth Third Bancorp now owns 1,485 shares of the technology company's stock valued at $36,000 after buying an additional 375 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in shares of Simulations Plus by 42.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock worth $72,000 after buying an additional 764 shares in the last quarter. Finally, AlphaQuest LLC boosted its stake in shares of Simulations Plus by 502.9% in the 4th quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock worth $75,000 after buying an additional 2,243 shares during the last quarter. Institutional investors and hedge funds own 78.08% of the company's stock.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 19.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages recently commented on SLP. Wall Street Zen raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. William Blair reaffirmed an "outperform" rating on shares of Simulations Plus in a research report on Tuesday, June 3rd. Craig Hallum cut their price target on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a report on Friday. Finally, KeyCorp raised their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, April 16th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $41.25.

Simulations Plus Price Performance

Shares of NASDAQ SLP traded down $0.12 during trading on Monday, reaching $18.95. 481,771 shares of the stock traded hands, compared to its average volume of 240,938. Simulations Plus, Inc. has a 52-week low of $18.66 and a 52-week high of $49.71. The company has a 50-day moving average of $30.64 and a 200-day moving average of $30.12. The stock has a market capitalization of $381.10 million, a P/E ratio of 47.38 and a beta of 0.97.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm's quarterly revenue was up 22.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.20 EPS. Analysts expect that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.